Herbert Watchel, Boehringer Ingelheim Pharma GmbH & Co. KG, DE - Qepler Summits And Conferences

Herbert Watchel

Senior Principal Scientist
Boehringer Ingelheim Pharma GmbH & Co. KG, DE
 At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health

Dr. Herbert Wachtel is a Senior Principal Scientist at Boehringer Ingelheim, Germany. Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies. Within its business unit Prescription Medicines, Respiratory is one of the major areas. Herbert has joined the company in 1998 and since then he has been involved in basics of inhalation therapy, e.g. formulation development, novel methods for particle sizing, design of aerodynamic components in inhalers and aerosol therapy in children. In his spare time Herbert serves as a lecturer on the subject of Pharmaceutical Technology at the Johannes Gutenberg-University in Mainz.

Herbert has studied Physics at the University of Stuttgart where he investigated conducting molecular solid films and surfaces before switching to the field of aerosolized drug delivery. Apart from CAD tools, Herbert regularly applies Computational Fluid Dynamics (CFD) and he advances up-to-date ‘in vivo-in vitro correlations’ (IV-IVC) for the optimization of devices in the industrial setting.

Related Sessions:

2nd Annual Inhaled
Drug Delivery Summit 2020

Assess and harness novel approaches to the development of inhaled drug products for enhanced patient care.
  • 30 Nov 2020
  • Virtual,
  • Pharma
Day 2: Tuesday, 01 December 2020
CASE STUDY: To Be Announced.
View Details